131 related articles for article (PubMed ID: 2460166)
21. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
Moulder JE; Fish BL
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
[TBL] [Abstract][Full Text] [Related]
22. Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
Teicher BA; Herman TS; Rose CM
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1187-92. PubMed ID: 3141321
[TBL] [Abstract][Full Text] [Related]
23. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
[TBL] [Abstract][Full Text] [Related]
24. Radiosensitization of murine tumors by Fluosol-DA 20%.
Lee I; Levitt SH; Song CW
Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
[TBL] [Abstract][Full Text] [Related]
25. Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.
Holden SA; Teicher BA; Ha C; Ara G; Herman TS
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):895-8. PubMed ID: 1391529
[TBL] [Abstract][Full Text] [Related]
26. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Teicher BA; Herman TS; Holden SA; Jones SM
J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
[TBL] [Abstract][Full Text] [Related]
27. Addition of a hypoxic cell selective cytotoxic agent (mitomycin C or porfiromycin) to Fluosol-DA/carbogen/radiation.
Holden SA; Herman TS; Teicher BA
Radiother Oncol; 1990 May; 18(1):59-70. PubMed ID: 2113698
[TBL] [Abstract][Full Text] [Related]
28. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
Martin DF; Porter EA; Fischer JJ; Rockwell S
Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
[TBL] [Abstract][Full Text] [Related]
29. Effects of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA.
Teicher BA; Rose CM
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1311-3. PubMed ID: 3093415
[TBL] [Abstract][Full Text] [Related]
30. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
Rockwell S; Mate TP; Irvin CG; Nierenburg M
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
[TBL] [Abstract][Full Text] [Related]
31. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
[TBL] [Abstract][Full Text] [Related]
32. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
[TBL] [Abstract][Full Text] [Related]
33. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Teicher BA; Holden SA; Rose CM
J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
[TBL] [Abstract][Full Text] [Related]
34. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
35. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
Lee I; Levitt SH; Song CW
Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
[TBL] [Abstract][Full Text] [Related]
36. Increase in tumor pO2 by perfluorochemicals and carbogen.
Hasegawa T; Rhee JG; Levitt SH; Song CW
Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):569-74. PubMed ID: 3104250
[TBL] [Abstract][Full Text] [Related]
37. Improvement in RBC flux, acidosis and oxygenation in tumour microregions by Fluosol-DA 20%.
Lee I; Cunningham WP; Levitt SH
Int J Radiat Biol; 1991 Oct; 60(4):695-705. PubMed ID: 1680148
[TBL] [Abstract][Full Text] [Related]
38. Variation in tumor response to fluosol-DA (20%).
Sasai K; Ono K; Nishidai T; Tsutsui K; Shibamoto Y; Takahashi M; Abe M
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1149-52. PubMed ID: 2497093
[TBL] [Abstract][Full Text] [Related]
39. Preclinical studies of a perfluorochemical emulsion as an adjunct to radiotherapy.
Rockwell S; Irvin CG; Kelley M
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):913-20. PubMed ID: 3141320
[TBL] [Abstract][Full Text] [Related]
40. Radiation enhancement of lung nodule formation in mice is not potentiated by treatment with a perfluorochemical emulsion and carbogen.
Rockwell S; Kelley M
Radiother Oncol; 1989 Jan; 14(1):49-53. PubMed ID: 2494685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
